I love the last couple of sentences in question number 2.....FU summer street!

Good article...laid it on a little thick with the sob story at the end though.

I'm in too....It's very difficult to begin a new thread on the other board and nobody seems to want to post. We should keep pro boards for other Biotech prospects and use this one for MNKD. The other board just doesn't feel right to me and its brought us and MNKD so bad mojo. Staying put!

http://beta.fool.com/leokornsun/2013/08/16/a-closer-look-at-two-niche-players-and-a-mainstrea/43469/

Well, they just took us down below 6.... Damn it!!!

Why would Deerfield agree to the second 4o million dollar tranche if there are any concerns with the dreamboat device?
Weren't these convertible notes subject to the achievement of studies 171 and 175 meeting all primary endpoints and safety issues that would prevent approval of Afrezza ?
Wouldn't they just back out if they new something was wrong?
You have to think they have been in direct contact with management and would probably know a bit more then we do about clinical trial results.